Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nucleic Acids Res ; 44(21): 10259-10276, 2016 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-27599846

RESUMO

PhIP is an abundant heterocyclic aromatic amine (HCA) and important dietary carcinogen. Following metabolic activation, PhIP causes bulky DNA lesions at the C8-position of guanine. Although C8-PhIP-dG adducts are mutagenic, their interference with the DNA replication machinery and the elicited DNA damage response (DDR) have not yet been studied. Here, we analyzed PhIP-triggered replicative stress and elucidated the role of the apical DDR kinases ATR, ATM and DNA-PKcs in the cellular defense response. First, we demonstrate that PhIP induced C8-PhIP-dG adducts and DNA strand breaks. This stimulated ATR-CHK1 signaling, phosphorylation of histone 2AX and the formation of RPA foci. In proliferating cells, PhIP treatment increased the frequency of stalled replication forks and reduced fork speed. Inhibition of ATR in the presence of PhIP-induced DNA damage strongly promoted the formation of DNA double-strand breaks, activation of the ATM-CHK2 pathway and hyperphosphorylation of RPA. The abrogation of ATR signaling potentiated the cell death response and enhanced chromosomal aberrations after PhIP treatment, while ATM and DNA-PK inhibition had only marginal effects. These results strongly support the notion that ATR plays a key role in the defense against cancer formation induced by PhIP and related HCAs.


Assuntos
Carcinógenos/toxicidade , Instabilidade Cromossômica/efeitos dos fármacos , Dano ao DNA/efeitos dos fármacos , Replicação do DNA/efeitos dos fármacos , Imidazóis/toxicidade , Estresse Fisiológico/efeitos dos fármacos , Estresse Fisiológico/genética , Animais , Proteínas Mutadas de Ataxia Telangiectasia/metabolismo , Bovinos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/genética , Quinase 1 do Ponto de Checagem/metabolismo , Aberrações Cromossômicas , Cricetinae , Adutos de DNA , Quebras de DNA de Cadeia Dupla , Receptores com Domínio Discoidina/metabolismo , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Humanos , Fosforilação , Transdução de Sinais/efeitos dos fármacos
2.
Food Chem Toxicol ; 95: 196-202, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27427305

RESUMO

High consumption of red meat entails a higher risk of developing colorectal cancer. Methionine, which is more frequently a component of animal proteins, and folic acid are members of the one carbon cycle and as such important players in DNA methylation and cancer development. Therefore, dietary modifications involving altered methionine and folic acid content might inhibit colon cancer development. In the present study, the BALB/c 3T3 cell transformation assay was used to investigate whether methionine and folic acid are able to influence the malignant transformation of mouse fibroblasts after treatment with the known tumour initiator 3-methylcholanthrene. Three different methionine concentrations (representing a -40%, a "normal" and a +40% cell culture medium concentration, respectively) and two different folic acid concentrations (6 and 20 µM) were thereby investigated. Methionine restriction led to a decrease of type III foci, while enhancement of both methionine and folic acid did not significantly increase the cell transformation rate. Interestingly, the focus-lowering effect of methionine was only significant in conjunction with an elevated folic acid concentration. In summary, we conclude that the malignant transformation of mouse fibroblasts is influenced by methionine levels and that methionine restriction could be a possible approach to reduce cancer development.


Assuntos
Transformação Celular Neoplásica/efeitos dos fármacos , Ácido Fólico/farmacologia , Metionina/deficiência , Complexo Vitamínico B/farmacologia , Animais , Células 3T3 BALB , Transformação Celular Neoplásica/induzido quimicamente , Transformação Celular Neoplásica/patologia , Células Cultivadas , Ensaio de Unidades Formadoras de Colônias , Metilcolantreno/toxicidade , Camundongos
3.
Arch Toxicol ; 90(5): 1093-102, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26070365

RESUMO

Colorectal cancer is one of the most frequent cancers in Western countries. Chronic intestinal diseases such as Crohn's disease and ulcerative colitis, in which the intestinal barrier is massively disturbed, significantly raise the risk of developing a colorectal tumour. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a genotoxic heterocyclic aromatic amine that is formed after strongly heating fish and meat. In this study, the hypothesis that PhIP uptake in the gut is increased during chronic colitis was tested. Chronic colitis was induced by oral administration of dextran sulphate sodium (DSS) to Fischer 344 rats. The transport of PhIP in eight different rat intestinal segments was examined in Ussing chambers. The tissues were incubated with 10 µM PhIP for 90 min, and the concentration of PhIP was determined in the mucosal and serosal compartments of the Ussing chambers as well as in the clamped tissues by LC-MS. Although chronic colitis was clearly induced in the rats, no differences in the intestinal transport of PhIP were observed between control and DSS-treated animals. The hypothesis that in the course of chronic colitis more PhIP is taken up by the intestinal epithelium, thereby increasing the risk of developing colorectal cancer, could not be confirmed in the present report.


Assuntos
Carcinógenos/metabolismo , Colite/metabolismo , Sulfato de Dextrana , Imidazóis/metabolismo , Absorção Intestinal , Mucosa Intestinal/metabolismo , Animais , Carcinógenos/toxicidade , Cromatografia Líquida , Doença Crônica , Colite/induzido quimicamente , Colite/patologia , Neoplasias do Colo/induzido quimicamente , Neoplasias do Colo/metabolismo , Modelos Animais de Doenças , Imidazóis/toxicidade , Intestinos/patologia , Cinética , Masculino , Ratos Endogâmicos F344 , Fatores de Risco , Espectrometria de Massas por Ionização por Electrospray
4.
Toxicol Lett ; 234(2): 92-8, 2015 Apr 16.
Artigo em Inglês | MEDLINE | ID: mdl-25707896

RESUMO

Previous studies have shown that in the rat, the colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is only absorbed to a limited extent in the small intestines and that a major fraction of unmetabolised PhIP reaches the colon. Moreover, PhIP is extensively metabolised when incubated with human stool samples to a major derivative, 7-hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido [3',2':4,5]imidazo[1,2-a]pyrimidin-5-ium chloride (PhIP-M1). In the present study, the uptake and transport of PhIP-M1 in Ussing chamber experiments, its cytotoxicity in the different segments of the Fischer 344 rat gut and its transforming potential in the BALB/c 3T3 cell transformation assay were analysed. At the most, 10-20% of the PhIP-M1 amount added to the mucosal compartment of the Ussing chambers per segment were absorbed within 90min. Therefore, the amount of PhIP-M1 detected in the tissues as well as in the serosal compartment of the Ussing chambers was extremely low. Moreover, human-relevant concentrations of PhIP-M1 were not cytotoxic and did not induce the malignant transformation of BALB/c 3T3 cells. In conclusion, even if one would assume that 100% of the daily amount of PhIP ingested by a human being is converted into PhIP-M1 in the colon, this concentration most probably would not lead to cytotoxicity and/or carcinogenicity in the colorectal mucosa.


Assuntos
Transformação Celular Neoplásica/induzido quimicamente , Imidazóis/metabolismo , Imidazóis/toxicidade , Absorção Intestinal , Mucosa Intestinal/metabolismo , Pirimidinas/metabolismo , Pirimidinas/toxicidade , Animais , Células 3T3 BALB , Relação Dose-Resposta a Droga , Cinética , Masculino , Camundongos , Ratos Endogâmicos F344 , Medição de Risco
5.
Arch Toxicol ; 87(12): 2201-14, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23708528

RESUMO

The aim of the present study was to determine whether the human adrenocortical carcinoma cell line H295R can be used as an in vitro test system to investigate the effects of binary pesticide combinations on estrone production as biological endpoint. In the first step ten pesticides selected according to a tiered approach were tested individually. The anilinopyrimidines cyprodinil and pyrimethanil as well as the dicarboximides iprodione and procymidone increased estrone concentration, while the triazoles myclobutanil and tebuconazole as well as the strobilurins azoxystrobin and kresoxim-methyl decreased estrone concentration in the supernatant of H295R cells. The N-methylcarbamate methomyl did not show any effects, and the phthalimide captan reduced estrone concentration unspecifically due to its detrimental impact on cellular viability. When cyprodinil and pyrimethanil, which belong to the same chemical group and increase estrone production, were combined, in most of the cases the overall effect was solely determined by the most potent compound in the mixture (i.e., cyprodinil). When cyprodinil and procymidone, which belong to different chemical groups but increase estrone production, were combined, in most cases an additive effect was observed. When cyprodinil, which increased estrone production, was combined with either myclobutanil or azoxystrobin, which decreased estrone production, the overall effect of the mixture was in most cases either entirely determined by myclobutanil or at least partially modulated by azoxystrobin. In conclusion, H295R cells appear to be an adequate in vitro test system to study the effect of combining two pesticides affecting estrone production.


Assuntos
Estrona/biossíntese , Praguicidas/toxicidade , Testes de Toxicidade/instrumentação , Testes de Toxicidade/métodos , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Meios de Cultura , Combinação de Medicamentos , Interações Medicamentosas , Análise de Alimentos , Frutas/química , Humanos , Resíduos de Praguicidas/análise , Verduras/química
6.
Arch Toxicol ; 87(5): 895-904, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23306951

RESUMO

Epidemiological studies show that a positive correlation exists between the consumption of strongly heated meat and fish and the development of colorectal tumours. In this context, it has been postulated that the uptake of toxic substances formed during meat and fish processing such as heterocyclic aromatic amines (HCAs) may be causally related to colon carcinogenesis. In a previous study, we have shown that 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most abundantly formed HCA in the above-mentioned food items, is mainly absorbed in the small intestine (i.e. proximal jejunum) of the rat. In the present study, we analysed whether PhIP can actively be secreted by enterocytes in the rat proximal jejunum and distal colon. Unidirectional PhIP flux rates from the mucosal-to-the serosal compartment (J ms ) and in the opposite direction (J sm ) were examined in Ussing chambers with (14)C-PhIP as radiotracer and in the absence of electrochemical gradients. Under these experimental conditions, significant negative net flux rates (J net  = J ms  - J sm ) can only be explained by an active secretion of PhIP into the luminal compartment, and such an effect was observed in the rat distal colon, but not in the proximal jejunum. Moreover, the data obtained suggest that the breast cancer resistance protein, the multidrug resistance protein 4 and P-glycoprotein are not involved in the active secretion of PhIP in the rat distal colon. The potential role of PhIP transport in colon carcinogenesis is discussed.


Assuntos
Adenocarcinoma/metabolismo , Carcinógenos/farmacocinética , Colo/metabolismo , Neoplasias do Colo/metabolismo , Enterócitos/metabolismo , Imidazóis/farmacocinética , Membro 1 da Subfamília B de Cassetes de Ligação de ATP/metabolismo , Membro 2 da Subfamília G de Transportadores de Cassetes de Ligação de ATP , Transportadores de Cassetes de Ligação de ATP/metabolismo , Adenocarcinoma/induzido quimicamente , Adenocarcinoma/patologia , Animais , Transporte Biológico , Carcinógenos/toxicidade , Colo/efeitos dos fármacos , Colo/patologia , Neoplasias do Colo/induzido quimicamente , Neoplasias do Colo/patologia , Enterócitos/efeitos dos fármacos , Enterócitos/patologia , Imidazóis/toxicidade , Jejuno/efeitos dos fármacos , Jejuno/metabolismo , Jejuno/patologia , Masculino , Proteínas Associadas à Resistência a Múltiplos Medicamentos/metabolismo , Ratos , Ratos Endogâmicos F344
7.
Arch Toxicol ; 86(5): 815-21, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22371238

RESUMO

In the present study, the effect of three controversially discussed risk factors for colorectal cancer, a fat-rich diet (16% raw fat content), dietary folic acid supplementation (50 mg folic acid/kg lab chow) and a human-relevant concentration (0.1 ppm) of the heterocyclic aromatic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), either alone or in combination, on the induction of aberrant crypt foci (ACF) in the colon of male Fischer 344 rats was analyzed. The mean number of ACF per rat in the case of the four groups fed a fat-rich diet tended to be higher than that of the four groups being fed a standard diet. However, the increase in the mean number of ACF per rat only reached statistical significance in the case of the rats receiving a fat-rich lab chow supplemented with 50 mg/kg folic acid. Moreover, a concentration of 0.1 ppm PhIP per se, either in the standard or in the fat-rich lab chow, did not lead to an increase in the mean number of ACF per rat. In conclusion, the present study provides additional evidence for a colon cancer promoting effect of folic acid supplementation when rodents are fed the compound in supraphysiological concentrations.


Assuntos
Focos de Criptas Aberrantes/induzido quimicamente , Colo/patologia , Neoplasias Colorretais/induzido quimicamente , Ácido Fólico/efeitos adversos , Imidazóis/toxicidade , Lesões Pré-Cancerosas/induzido quimicamente , Focos de Criptas Aberrantes/patologia , Animais , Colo/efeitos dos fármacos , Neoplasias Colorretais/patologia , Dieta Hiperlipídica , Suplementos Nutricionais , Humanos , Masculino , Lesões Pré-Cancerosas/patologia , Ratos , Ratos Endogâmicos F344 , Fatores de Risco
8.
Toxicol Lett ; 196(1): 60-6, 2010 Jun 16.
Artigo em Inglês | MEDLINE | ID: mdl-20382207

RESUMO

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a colon carcinogen in rats. In the present study the absorption of PhIP in the small and large intestine of Fischer 344 rats was determined, and the relevance of the differences in the degree of absorption of PhIP along the gastrointestinal axis for the PhIP-mediated colon carcinogenesis process is discussed. PhIP uptake was low in the different gut sections of Fischer 344 rats, the PhIP tissue levels varying in the following order: proximal jejunum>distal jejunum>proximal colon>distal colon=rectum. Furthermore, abcc2 was mainly expressed in the proximal parts of the small intestine, in particular in the proximal jejunum. Extremely low expression levels were observed in distal jejunum, ileum, caecum and proximal colon, whereas abcc2 was almost not detected in distal colon and rectum. These data, together with previously published results, lend support to the hypothesis that PhIP is taken up in the proximal segments of the small intestine and after being metabolically activated in the liver reaches the stem cell compartment of the colonic crypts via the blood circulation, the crypt cells in the distal colon and rectum being particularly at risk, since these almost do not express abcc2.


Assuntos
Carcinógenos/farmacocinética , Imidazóis/farmacocinética , Intestino Grosso/metabolismo , Intestino Delgado/metabolismo , Transportadores de Cassetes de Ligação de ATP/metabolismo , Animais , Carcinógenos/toxicidade , Neoplasias Colorretais/etiologia , Neoplasias Colorretais/genética , Imidazóis/toxicidade , Intestino Grosso/efeitos dos fármacos , Intestino Delgado/efeitos dos fármacos , Masculino , Ratos , Ratos Endogâmicos F344
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA